Catalent, Inc. to Present at the 37th Annual J.P. Morgan Health Care Conference
December 19 2018 - 4:15PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products, today announced that John
Chiminski, Chairman & Chief Executive Officer, will present at
the 37th Annual J.P. Morgan Health Care Conference at 10:30 a.m. PT
on Monday, January 7, 2019 in San Francisco, CA.
A live webcast of the presentations will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs over
11,000 people, including over 1,800 scientists, at more than 30
facilities across 5 continents and in fiscal 2018 generated
approximately $2.5 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181219005608/en/
Investor Contact:Thomas CastellanoCatalent, Inc.(732)
537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From Sep 2023 to Sep 2024